María Pellecchia L, Manuel Correa FJ. Comparison of clinical efficacy and dosing regimens between Nirsevimab and Palivizumab for prophylaxis against RSV in the pediatric population. SAP Primary Care [Internet]. 2025 Dec. 30 [cited 2026 Sep. 19];1:18. Available from: https://pc.southam.pub/index.php/pc/article/view/18